FDA’s data for FY 2018 (through September) indicates a record number of generic drug approvals and tentative approvals (971) for the year. Mean and median approval times, and other metrics, are published in the GDUFA II quarterly performance activities report.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
